Efficacy and safety of denosumab from a phase III, randomized, active-controlled study compared with zoledronic acid in patients of Asian ancestry with bone metastases from solid tumors

Authors :: Zefei Jiang
Yanmei Xu
Jie Dong
Wangjun Liao
Yang Yao
Li Zhang
Shukui Qin
Jianxing He
Ying Cheng
Qingyuan Zhang
Zhimin Shao
Source :: Journal of Clinical Oncology. 34:10116-10116
Publication Year :: 2016
Publisher :: American Society of Clinical Oncology (ASCO), 2016.
Abstract: 10116Background: This phase III double-blind study was conducted to provide bridging data to the available efficacy and safety data of denosumab (DmAb) from global skeletal-related events (SRE)-pre...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
03 medical and health sciences
0302 clinical medicine
Zoledronic acid
Denosumab
030220 oncology & carcinogenesis
Internal medicine
medicine
In patient
030212 general & internal medicine
business
medicine.drug

Full Text Access

Tools